Trigonella foenum graecum seed extract protects kidney function and morphology in diabetic rats via its antioxidant activity

Nutrition Research

Volumn 31, Issue 7, 2011, Pages 555-562

  Xue, Wanli ^a   Lei, Jing ^b   Li, Xuanshe ^a   Zhang, Ruijuan ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidant activity; Diabetic nephropathy; Morphology; Oxidative stress; Rats; Renal function; Trigonella foenum graecum

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CATALASE; CHOLESTEROL; CREATININE; DNA; INSULIN; LARD; MALONALDEHYDE; METFORMIN; NITROGEN; STREPTOZOCIN; SUCROSE; SUPEROXIDE DISMUTASE; TRIGONELLA FOENUM GRAECUM EXTRACT; UREA;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENZYME ACTIVITY; FENUGREEK; GLOMERULUS BASEMENT MEMBRANE; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY MASS; LOW DRUG DOSE; MALE; NONHUMAN; PLANT SEED; PRIORITY JOURNAL; RAT; RENAL PROTECTION; STOMACH INTUBATION; STREPTOZOCIN DIABETES; TREATMENT DURATION; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; URINE LEVEL;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD UREA NITROGEN; BODY WEIGHT; CATALASE; CREATININE; DEOXYGUANOSINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DIET; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; KIDNEY; MALE; MALONDIALDEHYDE; ORGAN SIZE; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SEEDS; SUPEROXIDE DISMUTASE; TRIGONELLA;

RATTUS; TRIGONELLA FOENUM-GRAECUM;

EID: 80051583976     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.05.010     Document Type: Article

References (43)

1. Drummond K., Mauer M. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 2002, 51:1580-1587.
2. White K.E., Bilous R.W. Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease. J Am Soc Nephrol 2000, 11:1667-1673.
3. Tervaert T.W., Mooyaart A.L., Amann K., Cohen A.H., Cook H.T., Drachenberg C.B., et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 2010, 21:556-563.
4. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003, 17:24-38.
5. Piwkowska A., Rogacka D., Audzeyenka I., Jankowski M., Angielski S. High glucose concentration affects the oxidant-antioxidant balance in cultured mouse podocytes. J Cell Biochem 2011, 112:1661-1672.
6. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40:405-412.
7. Sanders R.A., Rauscher F.M., Watkins J.B. Effect of quercetin on antioxidant defense in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001, 15:143-149.
8. Bonnefont-Rousselot D., Bastard J.P., Jaudon M.C., Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 2000, 26:163-176.
9. Raju J., Gupta D., Rao A.R., Yadava P.K., Baquer N.Z. Trigonella foenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol Cell Biochem 2001, 224:45-51.
10. Kumar G.S., Shetty A.K., Sambaiah K., Salimath P.V. Antidiabetic property of fenugreek seed mucilage and spent turmeric in streptozotocin-induced diabetic rats. Nutr Res 2005, 25:1021-1028.
11. Vijayakumar M.V., Singh S., Chhipa R.R., Bhat M.K. The hypoglycaemic activity of fenugreek seed extract is mediated through the stimulation of an insulin signalling pathway. Br J Pharmacol 2005, 146:41-48.
12. Hannan J.M., Ali L., Rokeya B., Khaleque J., Akhter M., Flatt P.R., et al. Soluble dietary fibre fraction of Trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action. Br J Nutr 2007, 97:514-521.
13. Kassaian N., Azadbakht L., Forghani B., Amini M. Effect of fenugreek seeds on blood glucose and lipid profiles in type 2 diabetic patients. Int J Vitam Nutr Res 2009, 79:34-39.
14. Xue W., Li X., Zhang J., Liu Y., Wang Z., Zhang R. Effect of Trigonella foenum-graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr 2007, 16:422-426.
15. Tripathi U.N., Chandra D. Anti-hyperglycemic and anti-oxidative effect of aqueous extract of Momordica charantia pulp and Trigonella foenum graecum seed in alloxan-induced diabetic rats. Indian J Biochem Biophys 2010, 47:227-233.
16. Genet S., Kale R.K., Baquer N.Z. Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues: effect of Vanadate and fenugreek (Trigonella foenum graecum). Mol Cell Biochem 2002, 236:7-12.
17. Kaviarasan S., Naik G.H., Gangabhagirathi R., Anuradha C.V., Priyadarsini K.I. In vitro studies on antiradical and antioxidant activities of fenugreek (Trigonella foenum graecum) seeds. Food Chem 2007, 103:31-37.
18. Kaviarasan S., Vijayalakshmi K., Anuradha C.V. Polyphenol-rich extract of fenugreek seeds protects erythrocytes from oxidative damage. Plant Foods Hum Nut 2004, 59:143-147.
19. Belguith-Hadriche O., Bouaziz M., Jamoussi K., El Feki A., Sayadi S., Makni-Ayedi F. Lipid-lowering and antioxidant effects of an ethyl acetate extract of fenugreek seeds in high-cholesterol-fed rats. J Agric Food Chem 2010, 58:2116-2122.
20. Al-Wabel N.A., Mousa H.M., Omer O.H., Abdel-Salam A.M. Biological evaluation of aqueous herbal extracts and stirred yoghurt filtrate mixture against alloxan-induced oxidative stress and diabetes in rats. Int J Pharm 2008, 4:135-139.
21. Thakran S., Siddiqui M.R., Baquer N.Z. Trigonella foenum graecum seed powder protects against histopathological abnormalities in tissues of diabetic rats. Mol Cell Biochem 2004, 266:151-159.
22. Hamden K., Masmoudi H., Carreau S., Elfeki A. Immunomodulatory, beta-cell, and neuroprotective actions of fenugreek oil from alloxan-induced diabetes. Immunopharmacol Immunotoxicol 2010, 32:437-445.
23. Petit P.R., Sauvaire Y.D., Hillaire-Buys D.M., Leconte O.M., Baissac Y.G., Ponsin G.R., et al. Steroid saponins from fenugreek seeds extraction, purification, and pharmacological investigation on feeding behaviour and plasma cholesterol. Steroids 1995, 60:674-680.
24. Al-Habori M., Raman A., Lawrence M.J., Skett P. In vitro effect of fenugreek extracts on intestinal sodium-dependent glucose uptake and hepatic glycogen phosphorylase A. Int J Exp Diabetes Res 2001, 2:91-99.
25. Dixit P., Ghaskadbi S., Mohan H., Devasagayam T.P. Antioxidant properties of germinated fenugreek seeds. Phytother Res 2005, 19:977-983.
26. Uemura T., Goto T., Kang M.S., Mizoguchi N., Hirai S., Lee J.Y., et al. Diosgenin, the main aglycon of fenugreek, inhibits LXRα activity in HepG2 cells and decreases plasma and hepatic triglycerides in obese diabetic mice. J Nutr 2011, 141:17-23.
27. Fossati P., Prencipe L., Beti G. Enzymatic creatinine assay: a new colorimetric method based on hydrogen peroxide measurement. Clin Chem 1983, 29:1494-1496.
28. Sun M., Zigman S. An improved spectrophotometric assay for superoxide dismutase based on epinephrine autoxidation. Anal Biochem 1978, 90:81-90.
29. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-126.
30. Jain S.K., McVie R., Duett J., Herbst J.J. Erythrocyte membrane lipid peroxidation and glycocylated hemoglobin in diabetes. Diabetes 1989, 38:1539-1543.
31. Saito S., Yamauchi H., Hasui Y., Kurashige J., Ochi H., Yoshida K. Quantitative determination of urinary 8-hydroxydexyguanosine (8-OHdG) by using ELISA. Res Commun Mol Pathol Oharmacol 2000, 107:39-44.
32. Knoll K.E., Pietrusz J.L., Liang M. Tissue-specific transcriptome responses in rats with early streptozotocin-induced diabetes. Physiol Genomics 2005, 21:222-229.
33. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002, 23:599-622.
34. Schleicher E.D., Wagner E., Nerlich A.G. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 1997, 99:457-468.
35. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997, 387:147-163.
36. Kitada M., Kume S., Imaizumi N., Koya D. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes 2011, 60:634-643.
37. Thuraisingham R.C., Nott C.A., Dodd S.M., Yaqoob M.M. Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney Int 2000, 57:1968-1972.
38. Kitada M., Koya D., Sugimoto T., Isono M., Araki S., Kashiwagi A., et al. Translocation of glomerular p47phox and p67phox by protein kinase C-β activation is required for oxidative stress in diabetic nephropathy. Diabetes 2003, 52:2603-2614.
39. Tsukahara H., Sekine K., Uchiyama M., Kawakami H., Hata I., Todoroki Y., et al. Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes. Pediatr Res 2003, 54:419-424.
40. Hodgkinson A.D., Bartlett T., Oates P.J., Millward B.A., Demaine A.G. The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy. Diabetes 2003, 52:846-851.
41. Koya D., Hayashi K., Kitada M., Kashiwagi A., Kikkawa R., Haneda M. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 2003, 14:S250-S253.
42. Rodriguez Z.Z., Guanche D., Alvarez R.G., Rosales F.H., Alonso Y., Schulz S. Preconditioning with ozone/oxygen mixture induces reversion of some indicators of oxidative stress and prevents organic damage in rats with fecal peritonitis. Inflamm Res 2009, 58:371-375.
43. Broca C., Breil V., Cruciani-Guglielmacci C., Manteghetti M., Rouault C., Derouet M., et al. Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat. Am J Physiol Endocrinol Metab 2004, 287:463-471.